Nanopatch is now dissolvable, according to researchers
UQ research has found the Nanopatch a needle-free, pain-free method of vaccine delivery is now dissolvable, eliminating the possibility of needle-stick injury.
Project leader Professor Mark Kendall, from the Australian Institute for Bioengineering and Nanotechnology, said the finding confirmed that the Nanopatch was a potential safer, cheaper alternative to needle vaccines.
The study was published recently in scientific journal Small.
What we have been able to show for the first time is that the Nanopatch is completely dissolvable, Professor Kendall said.
That means zero needles, zero sharps, zero opportunity for contamination and zero chance of needle-stick injury.
The World Health Organisation estimates that 30 percent of vaccinations in Africa are unsafe due to cross contamination caused by needle-stick injury. That's a healthcare burden of about $25 per administration.
The Nanopatch is smaller than a postage stamp and is packed with thousands of tiny projections invisible to the human eye now dried to include the vaccine itself together with biocompatible excipients.
When the patch is placed against the skin, these projections push through the outer skin layer and deliver the biomolecules to the target cells.
When dry, the device is stable and strong. When the Nanopatch is applied to the skin, the projections immediately become wet, dissolving within minutes.
Research published in journal Plos One in April found that the Nanopatch achieved a protective immune response using an unprecedented one-hundredth of the standard needle and syringe dose.
Professor Kendall said this was 10 times better than any other delivery method.
Being both painless and needle-free, the Nanopatch offers hope for those with needle phobia, as well as improving the vaccination experience for young children.
"When compared to a needle and syringe, a Nanopatch is cheap to produce and it is easy to imagine a situation in which a Government might provide vaccinations for a pandemic such as swine flu to be collected from a chemist or sent in the mail, Professor Kendall said.
He said the work had been in progress for five years and his team hoped to start clinical trials soon.
Source: University of Queensland /...
The Institute of Nanotechnology puts significant effort into ensuring that the information provided on its news pages is accurate and up-to-date. However, we cannot guarantee absolute accuracy. Consequently, the Institute of Nanotechnology disclaims any and all responsibility for inaccuracy, omission or any kind of deficiency in relation to the news items and articles hosted herein.
- 17 May 2013NanoSustain Factsheet and Case Studies
- 16 May 2013Making Gold Green: New Non-Toxic Method for Mining Gold
- 13 May 2013Cold atoms for quantum technology
- 02 May 2013Quantum information: Computing with a single nuclear spin in silicon
- 30 April 2013LESL launches start up challenge to celebrate 25th anniversary
- View All